No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone

Peterse, E.F.P.; Cleven, A.H.G.; Jong, Y. de; Briaire-de Bruijn, I.; Fletcher, J.A.; Danen, E.H.J.; ... ; Bovee, J.V.M.G. (2016)

Article / Letter to editor

• Chondrosarcoma
• IGF1R signalling
• Insulin-like growth factor
• OSI-906
• Sarcoma

• All authors: Peterse, E.F.P.; Cleven, A.H.G.; Jong, Y. de; Briaire-de Bruijn, I.; Fletcher, J.A.; Danen, E.H.J.; Cleton-Jansen, A.M.; Bovee, J.V.M.G.
• Date: 2016-07-14
• Journal: BMC Cancer
• Volume: 16
• DOI: doi:10.1186/s12885-016-2522-8